Shang Weilong, Yang Yi, Rao Yifan, Rao Xiancai
Department of Microbiology, College of Basic Medical Sciences, Army Medical University (Third Military Medical University), 400038 Chongqing, China.
NPJ Vaccines. 2020 Mar 6;5(1):18. doi: 10.1038/s41541-020-0170-0. eCollection 2020.
The outbreak of 2019-novel coronavirus disease (COVID-19) that is caused by SARS-CoV-2 has spread rapidly in China, and has developed to be a Public Health Emergency of International Concern. However, no specific antiviral treatments or vaccines are available yet. This work aims to share strategies and candidate antigens to develop safe and effective vaccines against SARS-CoV-2.
由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起的2019新型冠状病毒病（COVID-19）疫情已在中国迅速蔓延，并已发展成为一场国际关注的突发公共卫生事件。然而，目前尚无特异性抗病毒治疗方法或疫苗。这项工作旨在分享开发针对SARS-CoV-2的安全有效疫苗的策略和候选抗原。
